Publicacións (324) Publicacións nas que participase algún/ha investigador/a

filter_list

2025

  1. Adrenal mixed corticomedullary tumors: report of a case with molecular characterization and systematic review

    Virchows Archiv

  2. Correction to: Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey (Updates in Surgery, (2025), 10.1007/s13304-025-02111-6)

    Updates in Surgery

  3. Focal High-Grade Areas with a Tumor-in-Tumor Pattern: Another Feature of Pediatric DICER1-Associated Thyroid Carcinoma?

    Endocrine Pathology, Vol. 36, Núm. 1

  4. Histopathology of C Cells and Medullary Thyroid Carcinoma

    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, Vol. 223, pp. 9-50

  5. Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey

    Updates in Surgery

  6. Unraveling LINE-1 retrotransposition in head and neck squamous cell carcinoma

    Molecular Oncology

2024

  1. A prospective European trial comparing laparotomy, laparoscopy, robotic-assisted, and transanal total mesorectal excision procedures in high-risk patients with rectal cancer: the RESET trial

    Annals of Surgery

  2. Bilateral Uveal Melanoma: An Insight into Genetic Predisposition in Four New Unrelated Patients and Review of Published Cases

    Journal of Clinical Medicine, Vol. 13, Núm. 11

  3. Clinical Advantages and Limitations of Tumors Displaying Minimal and Extensive Vascular Invasion

    Thyroid FNA Cytology: Differential Diagnoses and Pitfalls, Third Edition (Springer Nature), pp. 119-130

  4. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  5. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  6. Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)

    Oncology reports, Vol. 52, Núm. 3

  7. Prognostic impact of log odds of positive lymph nodes (LODDS) in the stratification of patients with rectal cancer

    Cirugia Espanola, Vol. 102, Núm. 12, pp. 649-657

  8. The activity of therapeutic molecular cluster Ag5 is dependent on oxygen level and HIF-1 mediated signalling

    Redox Biology, Vol. 76

  9. Valoración de la anatomía patológica por los estudiantes de Medicina antes y después de las prácticas hospitalarias

    Perspectivas docentes en la educación superior (Educación Editora), pp. 53-56

  10. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

    Frontiers in Oncology, Vol. 13

  2. Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)

    Virchows Archiv, Vol. 482, Núm. 3, pp. 615-623

  3. Expert consensus on the integrated diagnosis of idiopathic multicentric Castleman disease

    Revista Espanola de Patologia, Vol. 56, Núm. 3, pp. 158-167

  4. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study

    British Journal of Haematology, Vol. 203, Núm. 2, pp. 182-193